Table 1 Clinicopathological Characteristics
Characteristics | ERp57 expression | ILF3 expression | ||||
|---|---|---|---|---|---|---|
Low (%) | High (%) | P value | Low (%) | High (%) | P value | |
Age | ||||||
  ≤ 56 years | 9 (50.00) | 9 (50.00) | 0.738 | 8 (42.11) | 11 (57.89) | 0.505 |
  > 56 years | 7 (41.18) | 10 (58.82) | 9 (56.25) | 7 (43.75) | ||
Gender | ||||||
 Male | 11 (45.83) | 13 (54.17) | 1.000 | 9 (39.13) | 14 (60.87) | 0.164 |
 Female | 5 (45.45) | 6 (54.55) | 8 (66.67) | 4 (33.33) | ||
Tumor size | ||||||
  ≤ 7 cm | 8 (80.00) | 2 (20.00) | 0.022 | 10 (76.92) | 3 (23.08) | 0.015 |
  > 7 cm | 8 (32.00) | 17 (68.00) | 7 (31.82) | 15 (68.18) | ||
pT status | ||||||
 pT1- pT2 | 7 (41.18) | 10 (58.82) | 0.738 | 9 (45.00) | 11 (55.00) | 0.738 |
 pT3 -pT4 | 9 (50.00) | 9 (50.00) | 8 (53.33) | 7 (46.67) | ||
pN status | ||||||
 pN0 | 12 (52.17) | 11 (47.83) | 0.476 | 8 (38.10) | 13 (61.90) | 0.176 |
 pN1 –pN3 | 4 (33.33) | 8 (66.67) | 9 (64.29) | 5 (35.71) | ||
TNM stage | ||||||
 I-II | 9 (42.86) | 12 (57.14) | 0.739 | 10 (52.63) | 9 (47.37) | 0.738 |
 III-IV | 7 (50.00) | 7 (50.00) | 7 (43.75) | 9 (56.25) | ||